Arrowhead appoints Hongbo Lu to board; board expands to eight, effective March 15

ARROWHEAD PHARMACEUTICALS, INC.

Hongbo Lu appointed to Arrowhead Board; board expanded from seven to eight, effective March 15, 2024.
Dr. Lu receives sign-on RSU grant of $761,666, vesting over three years.
Dr. Lu will receive standard non-employee director compensation as described in the 2024 proxy statement.
Dr. Lu has no family relationships with executives and no material interest in any related-party transactions.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Hongbo Lu

Director

ARWR · ARROWHEAD PHARMACEUTICALS, INC.

Effective: 2024-03-15
Filed: March 18, 2024, 7:59 PM ET

Appointment of Hongbo Lu as a Director

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Hongbo Lu was appointed as Director at ARROWHEAD PHARMACEUTICALS, INC..

Action: appointed
Role: Director

Exact text from the filing

Appointment of Hongbo Lu as a Director

View on SEC.gov

ARROWHEAD PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001628280-24-011557

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.